Holen Sie sich die Stockscreener-App
5.01
0.79%
-0.04
Handel nachbörslich:
4.93
-0.08
-1.60%
Finanzdaten der Atossa Therapeutics Inc-Aktie (ATOS)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
2.33%
9.251
|
9.04 | 7.414 | 7.151 | 6.385 |
| Operating Income/Loss |
2.33%
-9.251
|
-9.04 | -7.414 | -7.151 | -6.385 |
| Income/Loss From Continuing Operations Before Tax |
3.19%
-8.692
|
-8.423 | -6.718 | -6.347 | -7.23 |
| Income Tax Expense/Benefit |
-
|
- | - | - | - |
| Income/Loss From Continuing Operations After Tax |
3.19%
-8.692
|
-8.423 | -6.718 | -6.347 | -7.23 |
|
Net Income/Loss
|
3.19%
-8.692
|
-8.423 | -6.718 | -6.347 | -7.23 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.00%
129.17
|
129.17 | 129.17 | 0.2505 | 125.77 |
| Diluted Average Shares |
0.00%
129.17
|
129.17 | 129.17 | 0.2505 | 125.77 |
| Basic Earnings Per Share |
0.00%
-0.07
|
-0.07 | -0.05 | -0.05 | -0.06 |
| Diluted Earnings Per Share |
0.00%
-0.07
|
-0.07 | -0.05 | -0.05 | -0.06 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.48%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):